Recent Posts

Aqueous Film Forming Foam – AFFF

A Case Study by Stag Liuzza law firm HISTORY AND DEVELOPMENT OF FIREFIGHTING FOAMS  The first firefighting foam was developed in 1902 by Russian engineer and chemist Aleksandr Loran Loran was working in the oil and gas industry trying to find a substance to combat petroleum-based fires for which water is wholly ineffective Loran’s solution was the first firefighting foam which was able to extinguish oil and other flammable liquids-based fires by blanketing and smothering them Through the years, multiple advancements were made in the firefighting foam sector Beginning in the 1960’s, the Naval...

COVID-19 AND INSURANCE CLAIMS “WHAT YOU NEED TO KNOW”

(May 29, 2020) Governments and health authorities across the United States are responding to the outbreak of COVID-19 through the use of stay-at-home orders and other federal, state, and local orders in an attempt to disrupt the spread of COVID-19 As a result of these measures to disrupt the spread of COVID-19, many businesses have fallen on tough times and are looking to their commercial property insurance in an attempt to cover the losses they’ve experienced since the enactment of these protective measures through their policy’s business interruption insurance This article will explain what business...

ELMIRON LITIGATION: EMERGING TORTS

By Rachel Shkolnik, Hunter J Shkolnik Napoli Shkolnik, PLLC (May 27, 2020) The nationwide Elmiron eye damage litigation has picked up headlines over the past several months Elmiron, the brand name for pentosan polysulfate sodium, is a semi-synthetically produced heparin-like macromolecular carbohydrate derivative[1]  The lawsuit is centralized around the basis that the drug causes an eye disorder called maculopathy and other disorders of the retina that may lead to blindness  The lawsuits underlying claim is based on failing to properly warn the public about the risk of vision...

Talcum Powder Litigation: Status Report for Florida and Broward County

By Karina Rodrigues, Esq of Kelley | Uustal Trial Attorneys (May 18, 2020) Talcum powder litigation has grown exponentially in the past several years In 2013, a South Dakota jury reached a verdict in the first talc trial against Johnson & Johnson It found the company negligent but did not award 60-year-old Deane Berg damages In 2016, three trials resulted in combined verdicts exceeding $197 million Thereafter, 2017 brought two massive verdicts against the defendants—totaling over $527 million An astounding $47 billion verdict in a case involving 22 women and their families was later rendered by a...

The Truvada-Atripla Litigation And The Many Layers Involved

"Personal Injury-Patent Infringement COVID-19 Are All In The Mix" Click Here to view the FDA Link to the Truvada Label “Gilead Sciences and their Truvada/Atripla drug line are facing litigation on several fronts including patent infringement claims by the US Dept of Health and Human Services along with the personal injury claims and CDC research scrutiny on study protocols”  TDF is short for tenofovir disoproxil fumarate It is an HIV drug marketed by Gilead TDF drugs are sold under the following different brand names: Truvada (the most...

J&J TALC MDL DAUBERT OPINION: All Plaintiffs Experts Remain – Will Wolfson Ruling Lead to Settlement?

The long-awaited ruling by Judge Freda Wolfson in the Johnson & Johnson Talcum Powder MDL 2738 was issued April 27, 2020 In the opinion, the court ruled that plaintiffs could present evidence that J&J’s talcum powder products can cause ovarian cancer and that a jury must decide that question Talcum-Powder-MDL-2738-Daubert-Order-Freda-WolfsonDownload What does plaintiff leadership say Chris Tisi, of Levin Papantonio states:  “This is a significant ruling for the thousands of women whose cases await trial by jury in federal court  We look forward to presenting evidence that...

U.S. Office of Special Counsel Complaint & Disclosure Form

Rick Bright’s Primary Claims Include:Retaliation for Protected Activity An agency official is prohibited from taking, failing to take, or threatening to take or fail to take a against any employee or applicant for federal employment because of (A) the exercise of an appeal, complaint, or grievance right granted by any law, rule or regulation; (B) testifying or otherwise lawfully assisting any individual in the exercise of any such right; (C) cooperating with or disclosing information to the Inspector General (or any other component responsible for internal investigation or review) of any agency, or the...

COVID-19—Looking Beyond Tomorrow for Health Care and Society

JAMA-Journal of the American Medical Association Phil B Fontanarosa, MD, MBA1; Howard Bauchner, MD1 Author Affiliations Article Information JAMA Published online April 17, 2020 doi:101001/jama20206582 Related Articles  6 months ago, the novel coronavirus now known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19, the severe disease it causes, were unheard of Today, this highly contagious and dangerous virus and the widespread virulent disease it causes have resulted in major disruptions of business, education, and...

COVID-19 CLINICAL STUDY FROM CHINA PUBLISHED FEBRUARY 2020 IN LANCET MEDICAL JOURNAL

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study By:Chen, NS (Chen, Nanshan)[ 1 ] ; Zhou, M (Zhou, Min)[ 5,6 ] ; Dong, X (Dong, Xuan)[ 1 ] ; Qu, JM (Qu, Jieming)[ 5,6 ] ; Gong, FY (Gong, Fengyun)[ 2 ] ; Han, Y (Han, Yang)[ 3,10 ] ; Qiu, Y (Qiu, Yang)[ 10 ] ; Wang, JL (Wang, Jingli)[ 2 ] ; Liu, Y (Liu, Ying)[ 4 ] ; Wei, Y (Wei, Yuan)[ 1 ] More View ResearcherID and...

CHINESE MEDICAL STUDY ON COVID-19 THAT WAS REMOVED BY CHINESE GOVERNMENT ON MARCH 25, 2020

Study Title: Clinical Characteristics of Coronavirus Disease 2019 in China (references included) Fudan University Link:  https://webarchiveorg/web/20200409053204/http://wwwitfudaneducn/Data/View/3657 CONCLUSIONS: During the first 2 months of the current outbreak, Covid-19 spread rapidly throughout China and caused varying degrees of illness Patients often presented without fever, and many did not have abnormal radiologic findings (Funded by the National Health Commission of China and others) Abstract BACKGROUND Since December 2019, when coronavirus disease 2019 (Covid-19) emerged...